+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Boronic Acids 1648843-04-2
1648843-04-2,MFCD28502254
Catalog No.:AA01KKYP

1648843-04-2 | (2-(((5-((4-Fluorophenyl)carbamoyl)pyrimidin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronicacid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
97%
in stock  
$234.00   $164.00
- +
10mg
97%
in stock  
$322.00   $225.00
- +
25mg
97%
in stock  
$552.00   $387.00
- +
50mg
97%
in stock  
$870.00   $609.00
- +
100mg
97%
in stock  
$1,382.00   $968.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA01KKYP
Chemical Name:
(2-(((5-((4-Fluorophenyl)carbamoyl)pyrimidin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronicacid
CAS Number:
1648843-04-2
Molecular Formula:
C19H14BF4N3O4S
Molecular Weight:
467.2018
MDL Number:
MFCD28502254
SMILES:
Fc1ccc(cc1)NC(=O)c1cnc(nc1)SCc1cc(ccc1B(O)O)OC(F)(F)F
Properties

Downstream Synthesis Route

[1]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-US2015/38461,2015,A1

[1]Lu,Xin;Horner,JamesW.;Paul,Erin;Shang,Xiaoying;Troncoso,Patricia;Deng,Pingna;Jiang,Shan;Chang,Qing;Spring,DeniseJ.;Sharma,Padmanee;Zebala,JohnA.;Maeda,DeanY.;Wang,Y.Alan;Depinho,RonaldA.[Nature,2017,vol.543,#7647,p.728-732]

[2]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-JP2019/135244,2019,ALocationinpatent:Paragraph0128

[3]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-US2015/38461,2015,A1Locationinpatent:Paragraph0138-0139

[4]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-WO2015/16938,2015,A1Locationinpatent:Paragraph0128

[1]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-US2015/38461,2015,A1

[2]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-WO2015/16938,2015,A1

[3]Lu,Xin;Horner,JamesW.;Paul,Erin;Shang,Xiaoying;Troncoso,Patricia;Deng,Pingna;Jiang,Shan;Chang,Qing;Spring,DeniseJ.;Sharma,Padmanee;Zebala,JohnA.;Maeda,DeanY.;Wang,Y.Alan;Depinho,RonaldA.[Nature,2017,vol.543,#7647,p.728-732]

[4]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-JP2019/135244,2019,A

[1]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-US2015/38461,2015,A1

[2]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-JP2019/135244,2019,A

[1]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-US2015/38461,2015,A1

[2]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-WO2015/16938,2015,A1

[3]Lu,Xin;Horner,JamesW.;Paul,Erin;Shang,Xiaoying;Troncoso,Patricia;Deng,Pingna;Jiang,Shan;Chang,Qing;Spring,DeniseJ.;Sharma,Padmanee;Zebala,JohnA.;Maeda,DeanY.;Wang,Y.Alan;Depinho,RonaldA.[Nature,2017,vol.543,#7647,p.728-732]

[4]CurrentPatentAssignee:SYNTRIXBIOSYSTEMS-JP2019/135244,2019,A

Literature

Title: Sun L, et al. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight. 2019 Apr 4;4(7).

Title: Lu X, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017 Mar 30;543(7647):728-732. 

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1648843-04-2
Building Blocks
More >
Tags:1648843-04-2 Molecular Formula|1648843-04-2 MDL|1648843-04-2 SMILES|1648843-04-2 (2-(((5-((4-Fluorophenyl)carbamoyl)pyrimidin-2-yl)thio)methyl)-4-(trifluoromethoxy)phenyl)boronicacid